-
2
-
-
0001573232
-
-
Tedesco T., Kahan B., Mourad G., Vanrenterghem Y., Grinyo J., Weimar W., Pellet P., Chodoff L., Sablinski T. Am. J. Transplant. 1:2001;S243.
-
(2001)
Am. J. Transplant.
, vol.1
-
-
Tedesco, T.1
Kahan, B.2
Mourad, G.3
Vanrenterghem, Y.4
Grinyo, J.5
Weimar, W.6
Pellet, P.7
Chodoff, L.8
Sablinski, T.9
-
3
-
-
0032525049
-
-
Chiba K., Yanagawa Y., Yasubuchi Y., Kataoka H., Kawaguchi T., Ohtsuki M., Hoshino Y. J. Immunol. 160:1998;5037-5044.
-
(1998)
J. Immunol.
, vol.160
, pp. 5037-5044
-
-
Chiba, K.1
Yanagawa, Y.2
Yasubuchi, Y.3
Kataoka, H.4
Kawaguchi, T.5
Ohtsuki, M.6
Hoshino, Y.7
-
4
-
-
0037077308
-
-
Brinkmann V., Davis M.D., Heise C.E., Albert R., Cottens S., Hof R., Bruns C., Prieschl E., Baumruker T., Hiestand P., Foster C.A., Zollinger M., Lynch K.R. J. Biol. Chem. 277:2002;21453-21457.
-
(2002)
J. Biol. Chem.
, vol.277
, pp. 21453-21457
-
-
Brinkmann, V.1
Davis, M.D.2
Heise, C.E.3
Albert, R.4
Cottens, S.5
Hof, R.6
Bruns, C.7
Prieschl, E.8
Baumruker, T.9
Hiestand, P.10
Foster, C.A.11
Zollinger, M.12
Lynch, K.R.13
-
5
-
-
0037066466
-
-
Mandala S., Hajdu R., Bergstrom J., Quakenbush E., Xie J., Milligan J., Thornton R., Shei G.J., Card D., Keohane C., Rosenbach M., Hale J., Lynch C.L., Rupprecht K., Parsons W., Rosen H. Science. 296:2002;346-349.
-
(2002)
Science
, vol.296
, pp. 346-349
-
-
Mandala, S.1
Hajdu, R.2
Bergstrom, J.3
Quakenbush, E.4
Xie, J.5
Milligan, J.6
Thornton, R.7
Shei, G.J.8
Card, D.9
Keohane, C.10
Rosenbach, M.11
Hale, J.12
Lynch, C.L.13
Rupprecht, K.14
Parsons, W.15
Rosen, H.16
-
8
-
-
0005169797
-
-
Commercially available as OMe-ethers from Merck and Fluka
-
Commercially available as OMe-ethers from Merck and Fluka.
-
-
-
-
9
-
-
0005180150
-
-
Alternatively, D-cyclo-Val-Gly-OMe can be used
-
Alternatively, D-cyclo-Val-Gly-OMe can be used.
-
-
-
-
10
-
-
17144435270
-
-
Kiuchi M., Adachi K., Kohara T., Minoguchi M., Hanano T., Aoki Y., Mishina T., Arita M., Nakao N., Ohtsuki M., Hoshino Y., Teshima K., Chiba K., Sasaki S., Fujita T. J. Med. Chem. 43:2000;2946-2961.
-
(2000)
J. Med. Chem.
, vol.43
, pp. 2946-2961
-
-
Kiuchi, M.1
Adachi, K.2
Kohara, T.3
Minoguchi, M.4
Hanano, T.5
Aoki, Y.6
Mishina, T.7
Arita, M.8
Nakao, N.9
Ohtsuki, M.10
Hoshino, Y.11
Teshima, K.12
Chiba, K.13
Sasaki, S.14
Fujita, T.15
-
11
-
-
0005132154
-
-
The diastereomeric ratio (>10:1) of this step was irrelevant, since the stereochemical outcome of the overall sequence was determined by the following methylation
-
The diastereomeric ratio (>10:1) of this step was irrelevant, since the stereochemical outcome of the overall sequence was determined by the following methylation.
-
-
-
-
12
-
-
0005129128
-
-
4. After evaporation of the solvent the crude oil was purified by chromatography (hexanes/ether=9/1) to give the desired product as a slowly crystallizing oil (9.87 g, 22.2 mmol)
-
4. After evaporation of the solvent the crude oil was purified by chromatography (hexanes/ether=9/1) to give the desired product as a slowly crystallizing oil (9.87 g, 22.2 mmol).
-
-
-
-
13
-
-
0005162683
-
-
3)
-
3).
-
-
-
-
14
-
-
0005126746
-
-
Alternatively, bis-alkylated Schöllkopf adducts 7 can be synthesized from L-cyclo-Val-Ala-OMe by alkylation with iodide 6
-
Alternatively, bis-alkylated Schöllkopf adducts 7 can be synthesized from L-cyclo-Val-Ala-OMe by alkylation with iodide 6.
-
-
-
-
15
-
-
0005132157
-
-
Column: Chiracel OD (25×0.46 cm); Eluent: EtOH/hexane=1/1; UV detection at 210 nm; flow: 1 ml/min; injection: 20 mL 0.1% in EtOH; ee of (R)-3=95%
-
Column: Chiracel OD (25×0.46 cm); Eluent: EtOH/hexane=1/1; UV detection at 210 nm; flow: 1 ml/min; injection: 20 mL 0.1% in EtOH; ee of (R)-3=95%.
-
-
-
-
16
-
-
0005216011
-
-
2/THF
-
2/THF.
-
-
-
-
18
-
-
0005126520
-
-
-
-
-.
-
-
-
|